Hanne Due Rasmussen

Hanne Due Rasmussen is an Associate Professor at Aalborg University, affiliated with the Department of Haematology within The Faculty of Medicine. Her research focuses on understanding mechanisms of cancer progression, particularly in lymphoma and myeloma, with a strong emphasis on microRNA roles, drug resistance, and therapeutic strategies.

Her work integrates molecular biology techniques such as CRISPR-Cas9 screening and genomic analysis to identify novel therapeutic targets. Key areas of research include clonal evolution in multiple myeloma, CDCA2-driven cell proliferation in DLBCL, and DNA damage response pathways critical for cisplatin efficacy.

Publications highlight contributions to oncology and hematology, with a recent focus on drug resistance mechanisms and clinical biomarkers. Collaborations include studies on bendamustine resistance and Hsp90 inhibition strategies.